ALT A photo from the Images in Clinical Medicine article "Lung Hernia with a Chest-Wall Bulge" shows a patient with a visible chest-wall bulge sitting in a hospital room.
ALT A quote from a Perspective published in the New England Journal of Medicine reads as follows: "Surveillance of medical data … carries substantial privacy risks and could conceivably enable governments and companies to profile people on the basis of their current or predicted health status.” The Perspective is titled "Mass Surveillance with Artificial Intelligence — A New Determinant of Health?” and the authors are Nicholas Peoples, M.D., Katherine Hoops, M.D., J.D., M.P.H., and Eric W. Fleegler, M.D., M.P.H. The text is displayed on a simple white background with red border. The NEJM identity sits at the bottom.
ALT An illustrated diagram from a Review Article titled "Preventing Malaria Infections and Moving toward Malaria Elimination" from the New England Journal of Medicine. The diagram depicts the malaria transmission cycle, showing stages within the mosquito and human bloodstreams. It highlights vector control, vaccination, and other approaches to malaria prevention.
ALT This image contains three forest plots labeled A, B, and C, analyzing the effectiveness and risk differences of aspirin, rivaroxaban, and warfarin against various medical outcomes, including death, pulmonary embolism, deep vein thrombosis (VTE), major bleeding, and nonmajor bleeding. Each plot compares two medications and includes visual markers for risk differences with confidence intervals. Red markers indicate the noninferiority margin of 0.69 percentage points for each primary composite outcome.
ALT Two graphs show the percentage of any adjudicated acute pancreatitis event (Panel A) and the mean incidence of a first adjudicated pancreatitis event (Panel B) in the pooled plozasiran groups, as compared with the pooled placebo groups, in the SHASTA-3 and SHASTA-4 trials.
ALT This image contains an excerpt from the Research Summary "Interim Analysis of a Phase 3 Trial of Povetacicept in IgA Nephropathy” published in the New England Journal of Medicine. It includes a diagram of how povetacicept works. Participant details are summarized: 557 adults, mean age 43.5 years, 59% men, 41% women. Two groups are shown: 372 receive povetacicept, 185 receive a placebo, both administered subcutaneously every 4 weeks. A prompt to read the full Research Summary at NEJM.org sits at the bottom.
ALT The image is an illustration of a person standing by a hospital bed resting on a stack of books and a laptop that is embedded in the ground.
ALT Four medical images from the Images in Clinical Medicine article "Disseminated Bartonellosis." Panel A shows a healing scratch from the patient’s cat was noted on the medial right thigh. Panel B displays T1-weighted magnetic resonance imaging of the abdomen showing splenomegaly and lesions on the liver and spleen. Panel C is a photo of the spleen with whitish nodules. Panel D displays histopathological analysis of splenic tissue showing necrotizing granulomas.
ALT An illustration showing two ways for residents to draft clinical notes from encounters with patients. On the left, a resident is typing on a laptop, appearing focused. On the right, an AI scribe is taking notes while the resident speaks with a patient.
ALT A graph showing the total bilirubin and alanine aminotransferase levels over time for three patients. Each section includes labeled events like infusion, phenobarbital, and phototherapy. The x-axis represents years, while the y-axes represent total bilirubin (mg/dL). Different lines and markers indicate changes across the timeline for each patient.
ALT A quote from a Perspective published in the New England Journal of Medicine reads as follows: "Health data are still siloed in proprietary systems. Clinicians and patients feel the effects … when records don’t follow patients, histories must be retold, and tests must be repeated." The Perspective is titled "The Learning Health System, Made Computable" and the authors are Kenneth D. Mandl, M.D., M.P.H., J. Michael McGinnis, M.D., M.P.P., and Monica M. Bertagnolli, M.D. The background color is brown and includes the NEJM identity.
ALT The image contains six graphs. Graph A: The cumulative incidence of four-component primary end point of major adverse cardiovascular events (MACE) on treatment. Graph B: The cumulative incidence of three-component MACE on treatment. Graph C: The cumulative incidence of three-component MACE on treatment for composite of nonfatal MI, urgent coronary revascularization, or coronary heart disease (CHD) death. Graph D: The first and total_MACE events. Graph E: The cumulative incidence of the four-component MACE primary end point in landmark analysis with stratification of the pelacarsen group by lipoprotein(a) reduction after 3 months of treatment greater than or equal to and less than the median (170 nmol/l). Graph F: The cumulative incidence of the four-component MACE primary end point in landmark analysis with stratification of the pelacarsen group by achieved lipoprotein(a) after 3 months of treatment less than or equal to and greater than the median (69.5 nmol/l).
ALT A bullet list of key points from the Review Article "Intravenous Thrombolysis for Acute Ischemic Stroke — New Directions" on a yellow background. The New England Journal of Medicine identity sits at the bottom.
ALT A quote from a Perspective published in the New England Journal of Medicine reads as follows: "The United States is in the midst of a health care affordability crisis. Health insurance premiums and out-of-pocket costs strain households and employers, and public health care spending continues to grow. Yet the largest for-profit health insurers are generating substantial enterprise-level profits." The Perspective is titled "Private Health Insurance and Profit — Lessons for the United States" and the authors are Irene Papanicolas, Ph.D., and Jose F. Figueroa, M.D., M.P.H. The text is displayed on a simple white background with a gold border. The NEJM identity sits at the bottom.
ALT A visual representation of the RAINIER AIS-D08 trial, which tested whether povetacicept altered markers of nephropathy progression in IgA nephropathy.
ALT Four medical images from the Images in Clinical Medicine article "Hereditary Hemorrhagic Telangiectasia." Panel A: Photo of the patient's eye. Panel B: A photo of three of the patient's fingers. Panel C: A photo of the patient's tongue. Panel D: Computed tomography of the abdomen with the administration of contrast material.